(Q24188100)

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Impact of oral versus intravenous ibuprofen on neurodevelopmental outcome: a randomized controlled parallel study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Ibuprofen versus continuous indomethacin in premature neonates with patent ductus arteriosus: is the difference in the mode of administration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Effects of ibuprofen and indomethacin on urinary antidiuretic hormone excretion in preterm infants treated for patent ductus arteriosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Continuous infusion of ibuprofen for treatment of patent ductus arteriosus in very low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Treatment of patent ductus arteriosus with ibuprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Comparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Oral ibuprofen and ductus arteriosus closure in full-term neonates: a prospective case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Pulmonary hypertension following L-lysine ibuprofen therapy in a preterm infant with patent ductus arteriosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Prostanoids determine the range of cerebral blood flow autoregulation of newborn piglets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Cyclooxygenase isoenzymes and patency of ductus arteriosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Effects of indomethacin on cerebral haemodynamics in very preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Estimating the mean and variance from the median, range, and the size of a sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Variations in practice and outcomes in the Canadian NICU network: 1996-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Improved lung compliance after ligation of patent ductus arteriosus in hyaline membrane disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Oral ibuprofen versus intravenous ibuprofen or intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

A patent ductus arteriosus is associated with reduced middle cerebral artery blood flow velocity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

High-Dose Ibuprofen for Patent Ductus Arteriosus in Extremely Preterm Infants: A Randomized Controlled Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

Renal failure in the neonate associated with in utero exposure to non-steroidal anti-inflammatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

7 January 2021

Pulmonary hypertension in an infant treated with ibuprofen

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

7 January 2021

Determination of indomethacin and mefenamic acid in plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

7 January 2021

Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

7 January 2021

Comparative effects of indomethacin, prostaglandin E1, and ibuprofen on bowel ischemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

7 January 2021

Localized intestinal perforation following intravenous indomethacin in premature infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

7 January 2021

Medical management of small preterm infants with symptomatic patient ductus arteriosus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

7 January 2021

Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

7 January 2021

Ibuprofen treatment of patent ductus arteriosus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

7 January 2021

Oral Ibuprofen and ductus arteriosus in premature infants: a randomized pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

7 January 2021

Pharmacokinetics of mefenamic acid in preterm infants with patent ductus arteriosus.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

7 January 2021

Clinical aspects of very-low-birthweight infants showing reopening of ductus arteriosus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

7 January 2021

Comparison of ibuprofen and indometacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

7 January 2021

Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

7 January 2021

Age-dependent changes in the response of the lamb ductus arteriosus to oxygen and ibuprofen

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

7 January 2021

[Ibuprofen versus indomethacin in the treatment of patent ductus arteriosus in preterm infants]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

7 January 2021

Increased nitric oxide synthesis and action preclude choroidal vasoconstriction to hyperoxia in newborn pigs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

7 January 2021

Closure of the ductus arteriosus with indomethacin in ventilated neonates with respiratory distress syndrome. Effects of pulmonary compliance and ventilation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

7 January 2021

Differences in the effects in the newborn piglet of various nonsteroidal antiinflammatory drugs on cerebral blood flow but not on cerebrovascular prostaglandins

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

7 January 2021

Back to the drawing board

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

7 January 2021

Severe pulmonary hypertension with therapeutic L-lysine ibuprofen in 2 preterm neonates

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

7 January 2021

Treatment of patent ductus arteriosus (PDA) using ibuprofen: renal side-effects in VLBW and ELBW newborns

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

7 January 2021

Randomised controlled clinical trial of standard versus echocardiographically guided ibuprofen treatment for patent ductus arteriosus in preterm infants: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003481.PUB6

7 January 2021

10.1002/14651858.CD003481.PUB6

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

817518

817518

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference